Study: NCT05976698

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LSD 10 μg
Description: 0.5 h after the start of each study session the participants will be administered 10 μg LSD per os in the form of vials containing 1ml 20% EtOH (ethanol).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LSD 10 μg
Description: 0.5 h after the start of each study session the participants will be administered 10 μg LSD per os in the form of vials containing 1ml 20% EtOH (ethanol).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LSD 10 μg
Description: 0.5 h after the start of each study session the participants will be administered 10 μg LSD per os in the form of vials containing 1ml 20% EtOH (ethanol).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LSD 10 μg
Description: 0.5 h after the start of each study session the participants will be administered 10 μg LSD per os in the form of vials containing 1ml 20% EtOH (ethanol).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LSD 10 μg
Description: 0.5 h after the start of each study session the participants will be administered 10 μg LSD per os in the form of vials containing 1ml 20% EtOH (ethanol).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LSD 10 μg
Description: 0.5 h after the start of each study session the participants will be administered 10 μg LSD per os in the form of vials containing 1ml 20% EtOH (ethanol).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LSD 20 μg
Description: 0.5 h after the start of each study session the participants will be administered 20 μg LSD per os in the form of vials containing 1ml 20% EtOH.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LSD 20 μg
Description: 0.5 h after the start of each study session the participants will be administered 20 μg LSD per os in the form of vials containing 1ml 20% EtOH.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LSD 20 μg
Description: 0.5 h after the start of each study session the participants will be administered 20 μg LSD per os in the form of vials containing 1ml 20% EtOH.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LSD 20 μg
Description: 0.5 h after the start of each study session the participants will be administered 20 μg LSD per os in the form of vials containing 1ml 20% EtOH.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LSD 20 μg
Description: 0.5 h after the start of each study session the participants will be administered 20 μg LSD per os in the form of vials containing 1ml 20% EtOH.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LSD 20 μg
Description: 0.5 h after the start of each study session the participants will be administered 20 μg LSD per os in the form of vials containing 1ml 20% EtOH.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 0.5 h after the start of each study session the participants will be administered placebo per os in the form of vials containing 1ml 20% EtOH.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 0.5 h after the start of each study session the participants will be administered placebo per os in the form of vials containing 1ml 20% EtOH.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 0.5 h after the start of each study session the participants will be administered placebo per os in the form of vials containing 1ml 20% EtOH.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 0.5 h after the start of each study session the participants will be administered placebo per os in the form of vials containing 1ml 20% EtOH.